Carbamazepine is an anthropogenic pharmaceutical found in wastewater effluents that is quite resistant to removal by conventional wastewater treatment processes. Hydroxyl radicalbased advanced oxidation process can transform carbamazepine into degradation products but cannot mineralize it in an economically efficient manner. This study evaluated the combination of ultraviolet plus hydrogen peroxide (UV-H2O2)-based advanced oxidation and biodegradation to enable carbamazepine removal; specifically, to determine whether the products of the advanced oxidation of carbamazepine can be further biodegraded by activated sludge microbial communities. The fate of 14C–carbamazepine was followed through benchscale advanced oxidation followed by biodegradation using liquid scintillation counting, and by liquid chromatography with either a mass spectrometric or a radiochemical detection. The results illustrate that carbamazepine oxidation products can be mineralized by activated sludge bacteria.
This outcome suggests that combining advanced oxidation with a biologically active filtration treatment step can be effective for carbamazepine removal. This same treatment strategy should be evaluated for its effectiveness with other biologically recalcitrant organic micropollutants. Advanced oxidation followed by biodegradation may be a viable option for applying tertiary wastewater treatment to achieve trace contaminant removal.
This title belongs to WERF Research Report Series.
ISBN: 9781780400426 (eBook)
Download citation file: